Fidelis Capital Partners LLC Sells 31 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Fidelis Capital Partners LLC trimmed its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 944 shares of the semiconductor company’s stock after selling 31 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Synopsys were worth $562,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. ORG Partners LLC lifted its stake in Synopsys by 600.0% in the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 36 shares during the last quarter. University of Texas Texas AM Investment Managment Co. bought a new stake in shares of Synopsys in the fourth quarter valued at $28,000. Chris Bulman Inc purchased a new position in shares of Synopsys during the 2nd quarter valued at $30,000. Jones Financial Companies Lllp grew its stake in shares of Synopsys by 233.3% during the 4th quarter. Jones Financial Companies Lllp now owns 60 shares of the semiconductor company’s stock worth $31,000 after acquiring an additional 42 shares during the period. Finally, Fortitude Family Office LLC increased its holdings in Synopsys by 66.7% in the 2nd quarter. Fortitude Family Office LLC now owns 60 shares of the semiconductor company’s stock worth $36,000 after acquiring an additional 24 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on SNPS. Needham & Company LLC restated a “buy” rating and set a $640.00 price target on shares of Synopsys in a research note on Thursday, August 22nd. KeyCorp upped their price target on Synopsys from $675.00 to $690.00 and gave the company an “overweight” rating in a research report on Thursday, June 27th. Rosenblatt Securities reissued a “buy” rating and issued a $635.00 price target on shares of Synopsys in a report on Friday, August 23rd. Robert W. Baird boosted their price objective on shares of Synopsys from $661.00 to $663.00 and gave the company an “outperform” rating in a research note on Thursday, August 22nd. Finally, JPMorgan Chase & Co. increased their target price on shares of Synopsys from $655.00 to $685.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Eleven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $630.09.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 10,293 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total value of $5,701,189.77. Following the completion of the sale, the chief executive officer now owns 62,568 shares of the company’s stock, valued at $34,655,789.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, insider Geus Aart De sold 8,158 shares of the business’s stock in a transaction dated Thursday, June 27th. The stock was sold at an average price of $602.59, for a total value of $4,915,929.22. Following the completion of the sale, the insider now owns 106,983 shares of the company’s stock, valued at approximately $64,466,885.97. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 10,293 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total value of $5,701,189.77. Following the transaction, the chief executive officer now owns 62,568 shares in the company, valued at $34,655,789.52. The disclosure for this sale can be found here. Insiders sold 73,687 shares of company stock worth $44,616,637 in the last quarter. 0.66% of the stock is owned by insiders.

Synopsys Stock Performance

Synopsys stock opened at $506.65 on Monday. Synopsys, Inc. has a fifty-two week low of $440.62 and a fifty-two week high of $629.38. The stock has a market cap of $77.63 billion, a P/E ratio of 55.07, a price-to-earnings-growth ratio of 3.29 and a beta of 1.08. The firm’s fifty day moving average price is $525.96 and its 200-day moving average price is $556.52.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, August 21st. The semiconductor company reported $3.43 earnings per share for the quarter, beating analysts’ consensus estimates of $3.28 by $0.15. Synopsys had a return on equity of 22.09% and a net margin of 24.06%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter last year, the business posted $2.17 earnings per share. The company’s revenue for the quarter was up 12.7% on a year-over-year basis. On average, analysts predict that Synopsys, Inc. will post 9.45 earnings per share for the current year.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.